Cargando…

Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study)

Introduction: Small intestinal bacterial overgrowth (SIBO) leads to non-specific abdominal discomfort and nutrient malabsorption. Currently, rifaximin is widely applied in SIBO based on its antibacterial and non-absorbable nature. Berberine is a natural component of many popular medicine plants that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Huaizhu, Lu, Siqi, Zhang, Jindong, Chen, Chen, Du, Yanlin, Wang, Kun, Duan, Liping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974661/ https://www.ncbi.nlm.nih.gov/pubmed/36873985 http://dx.doi.org/10.3389/fphar.2023.1121435

Ejemplares similares

Role of Small Intestinal Bacterial Overgrowth (SIBO) and Inflammation in Obese Children
por: Esposito, Susanna, et al.
Publicado: (2020)

Does colectomy predispose to small intestinal bacterial (SIBO) and fungal overgrowth (SIFO)?
por: Rao, Satish S. C., et al.
Publicado: (2018)

Small intestinal bacterial overgrowth (SIBO) as a potential cause of impaired spermatogenesis
por: Tremellen, Kelton, et al.
Publicado: (2020)

The Role of Fecal Calprotectin in Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth (SIBO)
por: Polkowska-Pruszyńska, Beata, et al.
Publicado: (2020)

Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO) - A pilot study
por: Khalighi, A.R., et al.
Publicado: (2014)

Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection
por: Savva, K.-V., et al.
Publicado: (2021)

Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth
por: Chedid, Victor, et al.
Publicado: (2014)

Chinese herbal medicine for the treatment of small intestinal bacterial overgrowth (SIBO): A protocol for systematic review and meta-analysis
por: Ren, Xuetong, et al.
Publicado: (2020)

A Promising Approach: Artificial Intelligence Applied to Small Intestinal Bacterial Overgrowth (SIBO) Diagnosis Using Cluster Analysis
por: Hao, Rong, et al.
Publicado: (2021)

Distinct Effects of Non-absorbed Agents Rifaximin and Berberine on the Microbiota-Gut-Brain Axis in Dysbiosis-induced Visceral Hypersensitivity in Rats
por: Zhang, Jindong, et al.
Publicado: (2023)

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
por: Boltin, Doron, et al.
Publicado: (2014)

Fr582 A LOWER RISK FOR VITAMIN B12 DEFICIENCY DISTINGUISHES SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) CAUSED BY METHANE-PRODUCING ARCHAEA FROM SIBO CAUSED BY HYDROGEN-PRODUCING BACTERIA
por: Madigan, Katelyn E., et al.
Publicado: (2021)

Therapeutic efficacy of amoxicillin and rifaximin in patients with small intestinal bacterial overgrowth and Helicobacter pylori infection
por: Konrad, Paulina, et al.
Publicado: (2018)

Systematic review with meta‐analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth
por: Gatta, L., et al.
Publicado: (2017)

Effect of eradicating hydrogen-forming small intestinal bacterial overgrowth with rifaximin on body weight change
por: Lee, Seok-Hoon, et al.
Publicado: (2019)

Levothyroxine Sodium Oral Solution Normalizes Thyroid Function in a Patient with Hashimoto’s Disease, Gastritis, Diabetic Gastroparesis, and Small Intestinal Bacterial Overgrowth (SIBO)
por: Bohinc Henderson, Brittany
Publicado: (2021)

Serotonin Pathway of Tryptophan Metabolism in Small Intestinal Bacterial Overgrowth—A Pilot Study with Patients Diagnosed with Lactulose Hydrogen Breath Test and Treated with Rifaximin
por: Chojnacki, Cezary, et al.
Publicado: (2021)

Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis
por: Sakamaki, Akira, et al.
Publicado: (2020)

The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience
por: Fitriakusumah, Yoga, et al.
Publicado: (2019)

Brain Fogginess and SIBO: A Link or Just a Mirage?
por: Sachdeva, Sanjeev, et al.
Publicado: (2018)

Influence of Body Composition and Specific Anthropometric Parameters on SIBO Type
por: Wielgosz-Grochowska, Justyna Paulina, et al.
Publicado: (2023)

Effects of Bovine Colostrum with or without Egg on In Vitro Bacterial-Induced Intestinal Damage with Relevance for SIBO and Infectious Diarrhea
por: Playford, Raymond J., et al.
Publicado: (2021)

Response to Sachdeva et al: Brain Fogginess and SIBO Is Not a Mirage
por: Rao, Satish S. C., et al.
Publicado: (2018)

Association between Gut Dysbiosis and the Occurrence of SIBO, LIBO, SIFO and IMO
por: Banaszak, Michalina, et al.
Publicado: (2023)

Is it bowel-associated dermatosis-arthritis syndrome induced by small intestinal bacteria overgrowth?
por: Zhao, Hongjun, et al.
Publicado: (2016)

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Diet and intestinal bacterial overgrowth: Is there evidence?
por: Souza, Claudineia, et al.
Publicado: (2022)

Epidemiology of small intestinal bacterial overgrowth
por: Efremova, Irina, et al.
Publicado: (2023)

Small Intestinal Bacterial Overgrowths and Intestinal Methanogen Overgrowths Breath Testing in a Real-Life French Cohort
por: Plauzolles, Anne, et al.
Publicado: (2022)

Rifaximin Is Effective for the Treatment of Clostridium difficile—Associated Diarrhea: Results of an Open-Label Pilot Study
por: Rubin, David T., et al.
Publicado: (2011)

Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis
por: Rao, Satish S. C., et al.
Publicado: (2018)

Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice
por: Yang, Lianjun, et al.
Publicado: (2019)

Probiotic Formulations Containing Fixed and Essential Oils Ameliorates SIBO-Induced Gut Dysbiosis in Rats
por: Aslan, Ismail, et al.
Publicado: (2023)

Small intestinal bacterial overgrowth syndrome in children
por: Siniewicz-Luzeńczyk, Katarzyna, et al.
Publicado: (2015)

Small intestinal bacterial overgrowth in Alzheimer’s disease
por: Kowalski, Karol, et al.
Publicado: (2021)

Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice
por: Zhang, Shengyan, et al.
Publicado: (2023)

Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011)

The Use of Rifaximin in Patients With Cirrhosis
por: Caraceni, Paolo, et al.
Publicado: (2021)

The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Link between hypothyroidism and small intestinal bacterial overgrowth
por: Patil, Anant D.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_irb9eqropsb4s2r09dbc9blm2s